14.64 USD
▼-0.32-2.14%
盘后 12.88 0.00%
2026-09-15
市值
$1.58B
市盈率
—
EPS
-8.84
股息率
—
52 周区间
9.95 – 17.18
成交量
523.40K
Beta
0.48
目标价
18.00
52W 低 9.9552W 高 17.18
价格走势
公司简介
Freenome, Inc. operates as a biotechnology company in the United States. The company offers an early cancer detection platform that integrates multiomics, artificial intelligence, and machine learning to uncover complex biological signals associated with cancer. It develops blood-based tests, including a test for colorectal cancer screening, as well as tests for multi-cancer and multi-disease detection, such as lung, breast, cervical, liver, pancreatic, and esophageal cancers. The company was founded in 2014 and is headquartered in Brisbane, Ca...